Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Says Viberzi (eluxadoline) has an Increased Risk of Serious Pancreatitis in Patients without a G

americanpharmaceuticalreviewMarch 17, 2017

Tag: gallbladder , FDA

PharmaSources Customer Service